Major histocompatibility complex (MHC) class I molecules act as peptide receptors to direct the recognition of foreign antigens by cytolytic T cells. The cell surface expression and trafficking of these peptide receptors is thought to be controlled by the conformation of the MHC molecule and possibly by the phosphorylation of the cytoplasmic portion of the heavy chain protein. It is of some interest that adenoviruses (Ads) have evolved proteins that interfere with the expression of MHC molecules. One of these proteins, called E3/19k, binds to newly synthesized MHC molecules in the rough endoplasmic reticulum (RER) and inhibits their trafficking to the cell surface. Here we show that during the infection of a human cell line with Ad2, the phosphorylation of the endogenous MHC molecules is inhibited. We also observe that the phosphorylation of the endogenous HLA molecules is grossly impaired in a human cell line transfected with the Ad2 EcoRI D fragment containing the E3/19k gene. We conclude that the E3/19k protein inhibits the phosphorylation of the MHC heavy chains and that this may be one of the important functions of this protein in infected cells. In addition, we show that a mutant of the E3/19k protein, which lacks an PER retention signal but which retains its ability to bind to HLA molecules, does not inhibit the phosphorylation of HLA molecules and that phosphorylated molecules are not Endo H sensitive. This suggests that HLA molecules are phosphorylated after leaving the medialGolgi compartment, thus providing the most compelling evidence yet that HLA molecules are phosphorylated at or near the cell surface. Finally, to our knowledge, this is the first study under which the phosphorylation of MHC molecules is shown to be altered and may have some relevance for other pathogenic conditions.
Summary
Major histocompatibility complex (MHC) class I molecules act as peptide receptors to direct the recognition of foreign antigens by cytolytic T cells. The cell surface expression and trafficking of these peptide receptors is thought to be controlled by the conformation of the MHC molecule and possibly by the phosphorylation of the cytoplasmic portion of the heavy chain protein. It is of some interest that adenoviruses (Ads) have evolved proteins that interfere with the expression of MHC molecules. One of these proteins, called E3/19k, binds to newly synthesized MHC molecules in the rough endoplasmic reticulum (RER) and inhibits their trafficking to the cell surface. Here we show that during the infection of a human cell line with Ad2, the phosphorylation of the endogenous MHC molecules is inhibited. We also observe that the phosphorylation of the endogenous HLA molecules is grossly impaired in a human cell line transfected with the Ad2 EcoRI D fragment containing the E3/19k gene. We conclude that the E3/19k protein inhibits the phosphorylation of the MHC heavy chains and that this may be one of the important functions of this protein in infected cells. In addition, we show that a mutant of the E3/19k protein, which lacks an PER retention signal but which retains its ability to bind to HLA molecules, does not inhibit the phosphorylation of HLA molecules and that phosphorylated molecules are not Endo H sensitive. This suggests that HLA molecules are phosphorylated after leaving the medialGolgi compartment, thus providing the most compelling evidence yet that HLA molecules are phosphorylated at or near the cell surface. Finally, to our knowledge, this is the first study under which the phosphorylation of MHC molecules is shown to be altered and may have some relevance for other pathogenic conditions. T he mammalian class I antigens of the MHC are highly polymorphic cell surface glycoproteins. One of their major functions is to bind and then present viral peptides to CTL after viral infection (1, 2). Though each individual MHC class I protein may bind only to a small set of peptides during viral infections (3) (4) (5) , the extensive polymorphism between different MHC alleles and genes is believed to increase the capacity of this family of proteins to present a large variety of foreign viral antigens or peptides to virus-specific CTL. Thus, the extensive polymorphism may function on a population level to allow a species to withstand viral infections.
With such a great deal of polymorphism between MHC class I molecules, it is perhaps worth considering the common features of these molecules. They are composed of a heavy chain (mol wt 45,000) and a noncovalently associated light chain (mol wt 12,000) called fl2-microglobulin (6, 7) . The heavy chain has three extracellular domains, Oil, o~2, and oe3 (8) , each composed of ~90 amino acids, a transmembrane domain of "~30 amino acids, and a cytoplasmic region of "~30-40 residues (8) . The polymorphism resides primarily in the c~1 and a2 domains, whereas the oo domain and B2-microglobulin are relatively conserved (8) . The protein domain structure of the MHC class I antigens is consistent with the exon-intron organization of the corresponding genes (9). Thus, separate exons encode the signal sequence, the c~1, ol2, and c~3 domains, as well as the transmembrane segment. Surprisingly, the cytoplasmic region is encoded by three miniexons, each of them containing the information for ~10 amino acids (protein domains I1, I2, and Ia), and this region is a site of phosphorylation (10) (11) (12) (13) (14) . The crystal structure of the human class I proteins, HLA-A2 (15, 16) and HLA-Aw68 (17) confirms the domain structure and reveals that the oel and oe2 domains form a superdomain that is involved in peptide binding. This structure is stabilized by the a3 and B2-microglobulin domains, which lie proximal to the plasma membrane (15, 16) .
In addition to polymorphism arising from amino acid sub-stitution between MHC class I molecules, other mechanisms exist that increase their structural complexity. Alternative processing of MHC class I mRNA can result in modified transcripts thereby encoding several different proteins from a single gene (18, 19) . For example, exon VII, which encodes part of the intracytoplasmic region of MHC class I heavy chains (I2), is a site of alternative splicing at the mRNA level (14, 18, 19) . Splicing of the VII exon can result in the omission of 13 amino acids in the MHC heavy chain protein (14) . The I2 domain contains one site of serine phosphorylation at position 335 and possibly an additional site at position 332 (12) (13) (14) . Thus, alternative splicing of the immature mlLNA may result in the removal of a peptide structure containing a phosphorylation site(s). It is tempting to speculate that this mechanism has some functional significance, and that coordinate expression of alternatively spliced forms results in functional modification of MHC molecules, but at present, the data are incomplete. However, the phosphorylation of MHC class I molecules has been implicated in determining endocytic uptake from the cell surface and may function in downregulating surface expression of MHC class I molecules (10, 11) . The functional ramifications of this mechanism of downregulation are not clear. The E3/19k protein of adenovirus 2 (Ad2) 2 is a rough endoplasmic reticulum (REK) protein that spans the 1LEK membrane (20, 21) . It is thought to be a prime mediator of viral persistence (22) . It binds to MHC dass I proteins in the RER, inhibiting their passage to the cell surface (20, 21) , and thereby reducing the recognition of infected cells by virus specific T cells (23) (24) (25) (26) . This mechanism is thought to allow the virus to evade the host immune response (22) . We originally designed experiments to test whether the E3/19k protein is phosphorylated. This approach was chosen because we wanted to test whether ADP-ribosylation is a common signal for PER retention shared between luminal R.EtL proteins such as BIP (27) and integral RElL membrane proteins like E3/19k. We found that the E3/19k is not phosphorylated. Conversely, MHC molecules that are normally constitutively phosphorylated are nonphosphorylated in cells expressing the E3/19k protein.
Materials and Methods
Cell Culture, Cell Labelin,~ Imraunoprecipitation, and SDS-PAGE. Cell lines were derived and propagated as previously described (28, 29) . Cells were maintained in DMEM or c~MEM containing 10% FCS. The 621.13 cell line was the kind gift of Dr. Svne Kvist (Ludwig Institute, Stockholm, Sweden).
Metabolic labeling experiments were carried out essentially as described previously (28, 29) with the following modifications. Cells to be metabolically labeled were washed twice in methionine-free or phosphate-free media and incubated in the same media for 1 h at 37~ before being incubated at 37~ with [3SS]methionine (1,200 Ci/mmol, Amersham Corp., England) at a concentration 2Abbreviations used in this paper: Ad, adenovirus; AFU, arbitrary fluorescence units; hpi, hours post-infection; KER, rough endoplasmic reticulum. of 100/~Ci/ml for 15 min or 250/~Ci/ml of 32p-orthophosphate (9,000 Ci/mmol, Amersham Corp.) for 2 h. The cells were washed twice in cold complete medium. At this point, the ceils were lysed on the plate (20 mM "Iris, pH 7.6, 120 mM NaC1, 4 mM MgCI~, 1% NP-40, and 20 #g/ml PMSF). To clear the lysates from the cellular debris, the lysates were spun at 38,000 g for 30 min. The supernatants were incubated with 3 #1 of normal rabbit serum on ice for 15 min. Protein A-Sepharose (100 #1 of a 1:1 bufferAepharose slurry) was then added, and the mixtures were incubated for an additional 60 rain before being spun at 14,000 g for 5 min. Immunoprecipitations from the precleared lysates were carried out by incubating with 25 #1 of the rabbit antisera fluid or 100 #1 of mAb supernatant for 45 min, followed by 45 #1 of protein A-Sepharose for 60 min. The beads were washed and the proteins were analyzed by 10-15% SDS-PAGE and autoradiographed as described previously (28, 29) . When required, the beads were incubated for 30 h with Endo H buffer (70 mM NaCitrate, pH 5.5) with or without 2.5 mU of Endo H before analysis by SDS-PAGE.
Virus Propagation and Infection. Ad2 was propagated and titrated on 293 cells as described previously (30) . To assess the effect of Ad2 on the phosphorylation of MHC molecules, 293 cells were infected with Ad2 at an MOI of 50 or mock infected using PBS. After 40 min of adsorption at 37~ cells were incubated in DMEM containing calf serum and further incubated until metabolically labeled. HSV and CMV infection were carried out as described above for Ad2 except that infections were carried out with a MOI of 10. In the 0-2 h post-infection (hpi) time points, infection and phosphate starvation were done simultaneously and labeling media was added immediately after adsorption.
Antibodies. Rabbit antisera reacting with the E3/19k protein from Ad2 was a kind gift from Dr. William Wold (St. Louis University, St. Louis, MO). W6/32 (anti-HLA-A, -B, -C) (31) was prepared from hybridoma supernatant. Goat anti-mouse IgG FITC was obtained from Southern Biotechnology.
FACS | To verify cell surface expression of the HLA antigen, FACS | analysis was carried out (Becton Dickinson & Corp., Mountain View, CA). Mock or virus-infected 293 cells or transfected 293.12 and 621.13 ceils were harvested from petri dishes by washing the cells twice with PBS and then incubating with versene. A single cell suspension was prepared and the cells were then washed twice in PBS containing 0.5% (wt/vol) BSA, 20 mM NAN3, and 20 mM Hepes. The cells were incubated with mAbs as previously described (28, 29) , except that FITC-conjugated goat anti-mouse IgG was used as the second-step reagent. After labeling, the cells were fixed in 1.5% (vol/vol) p-formaldehyde. The fluorescent profiles were obtained by analyzing 5,000 cells in a semi-logarithmic plot using a FACScan | program. Conversion of log scale to linear scale mean fluorescent values was carried out using the equation: linear mean fluorescence = 100o~ r~,n auo~cen~/256 channels)
Other Reagents. Protein A-Sepharose was from Pharmacia Fine Chemicals (Uppsala, Sweden).
Results
The FACS | analysis shown in for mock-treated cell is 93 AFU. The no first antibody control is the same for both cell treatments (2 AFU). Thus, the inhibition of MHC surface expression after Ad2 infection in the experiment shown was 66%. In six independent experiments, the inhibition was on average 61% + 4. [20] [21] [22] hpi. The cells were lysed in NP-40 containing lysis buffer, and the cellular debris was removed by ultracentrifugation at 38,000 g for 30 rain. Antibodies against HLA molecules were used to specifically immunoprecipitate these proteins from equal numbers of TCA-precipitable counts, as assessed by scintillation counting. The immunoprecipitates were analyzed on a 10-15% gradient SDS-PAGE followed by autoradiography. In mock-infected 293 cells labeled with 32p-orthophosphate (Fig. 3 A) , MHC proteins are clearly phosphorylated. In cells infected with Ad2, which encodes a functional E3/19k protein, the phosphorylated form of MHC proteins is substantially inhibited. This inhibition of phosphorylation mirrors the maximum inhibition of HLA surface expression, which takes place 16-24 hpi (Fig. 1) . Densitometry traces indicate that the phosphorylation of MHC class I molecules is reduced by ;>60% in Ad2-infected cells compared to mock-treated 293 cells. In five independent experiments, the decrease of phosphorylation was 66% +_ 4.
In an attempt to generalize these findings to other viral systems, the phosphorylation of MHC molecules expressed in HSV-and CMV-infected cells was examined. Vero cells, which are permissive for HSV-1 infections, were infected with HSV-1 and then metabolically labeled with 32p-orthophosphate 22-24 hpi. The cell lysates were prepared as before and immunoprecipitations were carried out from equal numbers of TCA precipitable counts with the W6/32 antibody. Similarly, CMV was used to infect MRC5 cells, and the phosphorylation of MHC molecules was compared between virusinfected and noninfected cells. Fig. 3 , B and C shows that there is little difference between the virus-infected and the mock-treated cells up to 22 hpi nor at times before this time (data not shown). Thus, we conclude that two members of the herpes virus group, CMV and HSV-1, do not inhibit the phosphorylation levels of MHC molecules up to 22 hpi. gene, called 293.12 cells (20) , with the EcoRI D fragment containing the 621 gene (32) , or untransfected 293 cells, were metabolically labeled with either 3SS-methionine or with 32p. orthophosphate and immunoprecipitations were carried out as described above. In 3SS-methionine-labeled 293.12 cells, the antibody against MHC proteins clearly immunoprecipitates the MHC molecule with the E3/19k bound to it, whereas in the untransfected 293 cells HLA, but not the E3/19k protein, was detected (Fig. 4) . In addition, the 621 protein can be detected by coimmunoprecipitation with HLA molecules in 621-transfected cells. The 621 runs at a slightly lower molecular weight than the E3/19k protein in coimmunoprecipiration with HLA molecules (Fig. 4) . Unfortunately, the rabbit antisera we are using was raised against a synthetic peptide (33) that corresponds to the P E R retention signal absent in the 621 protein (32) . Thus, we can not analyze this protein directly.
In the 293 cells metabolically labeled with 32p-orthophosphate, HLA class I molecules are phosphorylated. However, in the E3/19k transfectant the phosphorylation of the MHC is dramatically inhibited. The weak signal that does appear represents 24% of the HLA phosphorylation level in 293 cells (mean of 19% + 4 in five independent experiments). The immunoprecipitations were carried out from equal numbers of TCA-precipitable counts. Normalization of the 32p labeling with the 35S-methionine labeling reveals an even greater level of inhibition of HLA phosphorylation. The small amount of phosphorylated HLA in 293.12 cells may be molecules that avoid binding to the E3/19k protein or they may represent a form of the HLA molecules that are phosphorylated at an alternative site other then serine 335, which is not affected by the E3/19k protein. The identity of this molecular form of phosphorylated HLA molecules is under investigation. We conclude that the EcoRI D fragment of Ad2 contains the information necessary to transfer the inhibition of phosphorylation of HLA molecules. In addition, we conclude that the E3/19k protein is not itself phosphorylated (Fig. 4) .
We next wanted to determine whether the retention of HLA molecules in the RER was responsible for the inhibition of HLA phosphorylation or whether it was a result of an additional activity associated with the E3/19k protein.
We therefore analyzed the phosphorylation of HLA molecules in the presence of the 621 protein. We find that the phosphorylation of HLA molecules is not effected in these cells (Fig. 4) . The apparent increase in the level of phosphorylation of the MHC molecules shown in this particular experiment (239% compared to 293 cells) is not reproducible (134% _+ 37 in four experiments). We infer from this data that the inhibition of phosphorylation is a consequence of inhibiting HLA transport through the cell. Alternatively, the COOH-terminal RER retention signal absent in the 621 protein contains an activity that directly mediates the hypophosphorylation of HLA molecules.
Finally, the glycosylation of the phosphorylated forms of HLA molecules in 293 and 293.12 cells was analyzed. HLA molecules from 32p-labeled 293 and 293.12 cells were immunoprecipitated in duplicate. One of each of the samples was digested overnight in buffer containing Endo H. The dupli-
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Lipp6 et al. cates of these samples were incubated in buffer alone. Endo H resistance is a marker of glycoproteins that have left the cis/medial Golgi compartment. At the end of the incubation SDS-PAGE loading buffer was added, and the samples were separated by SDS-PAGE. The gel was dried and autoradiography was performed. Fig. 5 shows that the vast majority of phosphorylated HLA molecules in 293 or 293.12 cells are not Endo H sensitive. This experiment suggests that HLA molecules become phosphorylated after they leave the cis/medial Golgi compartment. It also suggests that the majority of the phosphorylated form of the HLA molecules seen in the 293.12 cells are molecules that have escaped E3/19k-mediated retention in the PER.
Discussion
Ads have developed several mechanisms for evading the host immune system (17, 20, 21, 34) . In fact, the E3 region of Ad, which is dispensable for viral replication in tissue culture (34) , may act as a specific expression cassette for downregulating the host immune response. The E3/19k protein is likely to be the most abundant protein encoded by the E3 region (34) . It binds to MHC class I molecules in the RER, thereby inhibiting their transport to the cell surface (20, 21) . It appears that the E3/19k protein is arranged in functional protein domains including an intraluminal domain that interacts with a region of the c~1 and or2 domains of MHC class I molecules (28) . This region of class I MHC molecules also controls their rate of transport to the cell surface. A second domain acts jointly as a stop transfer sequence and a transmembrane region. Finally, the cytoplasmic tail of the molecule appears to contain the information for confining the E3/19k molecule, and the MHC protein to which it is bound, to the RER (35) .
Protein phosphorylation is thought to regulate several cellular processes including signal transduction, mitosis, cell proliferation, cell motility, cell shape, and gene regulation (36) . Its role in the trafficking of proteins through the exocytic pathway is only now being assessed. The study of MHC class I molecules provides an opportunity for determining the rules for phosphorylational control of protein transport. A great deal is known about how MHC class I assembly and conformation control their passage through the cell. For example, it is known that the variation between the MHC heavy chain alleles controls their rate of transport through the cell (28), binding to peptides (3) , and the binding of the E3/19k protein (28) . We also know that peptides bind during the assembly of class I heavy chains with ~2-microglobulin (37) . Furthermore, site-specific phosphorylation including and in addition to the major site of phosphorylation at serine 335 may modulate distinct routing of MHC class I molecules through the cell (10, 11) . Finally, alternative splicing of exon VII, which contains the major sites of phosphorylation in MHC class I molecules, may yet prove to have a profound effect on the antigen-presenting function of class I molecules (10, 11, 14) . Unfortunately, we are still lacking a direct demonstration that HLA class I molecules become phosphorylated exclusively at the plasma membrane. The only real support for this is that PMA, a potent activator of plasma membraneassociated protein kinase C, causes hyperphosphorylation of HLA molecules (10) and that deletion of exon VII containing two phosphorylation sites alters the rate of endocytosis of HLA molecules (10, 11) . In the present study, we sought to approach this issue.
During infection with Ad2, we find that the cell surface expression of MHC molecules decreases (Fig. 1) . This effect is maximized 16-20 hpi. The level of phosphorylation of the MHC molecules was measured at the peak of the inhibition of MHC surface expression. To show that the inhibition of phosphorylation is not merely a result of the lowered expression of MHC molecules after infection with Ad2, we examined a cell line that constitutively expresses the E3/19k protein. We found that we could detect the binding of the E3/19k protein to MHC molecules. Furthermore, the phosphorylation of MHC molecules is dramatically reduced in the cells that express the E3/19k protein. We conclude from these studies that the E3/19k protein can inhibit the phosphorylation of MHC class I proteins. Recently, it was shown that the EcoKI D fragment of Ad2 encodes another protein, 6.7k (38) . The role of this protein in the formation of the E3/19k-MHC class I complex is unknown but is under investigation.
The mechanism by which the E3/19k protein reduces the level of MHC class I heavy chain phosphorylation is still unclear. We decided to examine if the E3/19k protein inhibits the phosphorylation of MHC molecules by inhibiting their transport out of the REK, if it acts directly on the MHC proteins to inhibit phosphorylation, or if it actively dephosphorylates MHC molecules. For example, does phosphorylation of MHC molecules control their egress or transport to the cell surface. We therefore examined HLA phosphorylation in 293 cells expressing a form of the E3/19k protein called 621, which lacks a peptide from the COOH terminus, which confers REK retention to the HLA-E3/19k complex (35) . The 621 protein retains its ability to bind to HLA class I proteins. We found that phosphorylation is not inhibited in cells expressing the 621 protein. Therefore, either the PER retention signal actively participates in dephosphorylating or inhibiting the phosphorylation of HLA molecules, or retention in the RER does not allow HLA molecules to gain access to enzymes that phosphorylate them. We favor the latter scenario, as it would suggest that HLA molecules must leave the KER/cis-Golgi compartments in order to become fully phosphorylated. In further support of this hypothesis is the demonstration that the vast majority of phosphorylated HLA molecules expressed in 293 and 293.12 cells are not Endo H sensitive (Fig. 5 ). This suggests that the HLA molecules must leave the cis/medial Golgi in order to become phosphorylated and that most of the residually phosphorylated HLA molecules expressed in 293.12 cells are molecules that have escaped E3/19k mediated retention in the REK. In this regard, this is the best data yet presented that HLA molecules are indeed phosphorylated in a cellular compartment beyond the medial Golgi compartment, and it supports the notion that HLA molecules may become phosphorylated at the cell surface.
In the future, our ability to modify MHC molecules and to express them in cell lines (28) and transgenic animals (29) should allow us to determine the exact role of MHC class I protein phosphorylation. In addition, the E3/19k protein may be useful as a tool to alter the phosphorylation of MHC class I molecules. Regardless of the outcome of these experiments, the results reported here add another level of complexity to the molecular pathogenesis of Ads.
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